Acknowledgements
  Supported by NIH grants DK36256 and DK44128.

  1. Gross J, Pitt-Rivers R 1951. Unidentified iodine compounds in human plasma in addition to thyroxine and iodide. Lancet 2:766-769.


  2. Pitt-Rivers R, Stanbury JB, Rapp B 1955. Conversion of thyroxine to 3-5-3'-triiodothyronine in vivo. Journal of Clinical Endocrinology and Metabolism 15:616-620.


  3. Oppenheimer JH, Schwartz HL, Surks MI 1972. Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine: An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone. J Clin Invest 51:2493-2497.


  4. Chopra IJ, Solomon DH, Chopra U, Wu SY, Fisher DA, Nakamira Y 1978. Pathways of metabolism of thyroid hormones. Recent Prog Horm Res 34:521-657.


  5. Leonard, J.L. and Visser, T.J. Biochemistry of deiodination. In: Thyroid Hormone Metabolism, edited by Hennemann, G. New York: Marcel Dekker, 1986, p. 189-229.


  6. Silva JE, Larsen PR 1977. Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science 198:617-620.


  7. Visser TJ, Leonard JL, Kaplan MM, Larsen PR 1982. Kinetic evidence suggesting two mechanisms for iodothyronine 5'-deiodination in rat cerebral cortex. Proc Natl Acad Sci USA 79:5080-5084.


  8. Larsen PR, Silva JE, Kaplan MM 1981. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev 2:87-102.


  9. Kaplan MM, Yaskoski KA 1980. Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates. J Clin Invest 66:551-552.


  10. Berry MJ, Banu L, Larsen PR 1991. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349:438-440.


  11. Larsen PR, Berry MJ 1995. Nutritional and hormonal regulation of thyroid hormone deiodinases. Ann Rev Nutr 15:323-352.


  12. Berry MJ, Banu L, Chen Y, Mandel SJ, Kieffer JD, Harney JW, Larsen PR 1991. Recognition of UGA as a selenocysteine codon in type I deiodi Referencesnase requires sequences in the 3' untranslated region. Nature 353:273-276.


  13. Low SC, Berry MJ 1996. Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem Sci 21:203-208.


  14. Toyoda N, Berry MJ, Harney JW, Larsen PR 1995. Topological analysis of the integral membrane protein, type 1 iodothyronine deiodinase (D1). J Biol Chem 270:12310-12318.


  15. Berry MJ, Larsen PR 1992. The role of selenium in thyroid hormone action. Endocr Rev 13:207-219.


  16. Berry MJ, Larsen PR 1994. Selenocysteine and the structure, function, and regulation of iodothyronine deiodination: update 1994. Endocr Rev 3:265-269.


  17. Toyoda N, Zavacki AM, Maia AL, Harney JW, Larsen PR 1995. A novel retinoid X receptor- independent thyroid hormone response element is present in the human Type 1 deiodinase gene. Mol Cell Biol 15:5100-5112.


  18. Croteau W, Davey JC, Galton VA, St.Germain DL 1996. Cloning of the mammalian Type II iodothyronine deiodinase: a selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98:405-417.


  19. Salvatore D, Bartha T, Harney JW, Larsen PR 1996. Molecular biological and biochemical characterization of the human Type 2 selenodeiodinase. Endocrinology 137:3308-3315.


  20. Davey JC, Becker KB, Schneider MJ, St.Germain DL, Galton VA 1995. Cloning of a cDNA for the type II iodothyronine deiodinase. J Biol Chem 270:26786-26789.


  21. Salvatore D, Tu H, Harney JW, Larsen PR 1996. Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 98:962-968.


  22. Silva JE, Larsen PR 1985. The potential of brown adipose tissue type II T4 5'-deiodinase as a local and systemic source of T3 in rats. J Clin Invest 76:2296-2305.


  23. Abuid J, Larsen PR 1974. Triiodothyronine and thyroxine in hyperthyroidism. J Clin Invest 54:201- 208.


  24. Saberi M, Sterling FH, Utiger RD 1975. Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. J Clin Invest 55:218-223.


  25. Geffner DL, Azukizawa M, Hershman JM 1975. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest 55:224-229.


  26. Lum SM, Nicoloff JT, Spencer CA, et al. 1984. Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man. J Clin Invest 73:570-575.


  27. Inada M, Kasagi K, Kurata S, Kazama Y, Takayama H, Torizuka K, Fukase M, Soma T 1975. Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man. J Clin Invest 55:1337-1348.


  28. Mandel SJ, Berry MJ, Kieffer JD, Harney JW, Warne RL, Larsen PR 1992. Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase. J Clin Endocrinol Metab 75:1133-1139.


  29. Salvatore D, Low SC, Berry MJ, Maia AL, Harney JW, Croteau W, St.Germain DL, Larsen PR 1995. Type 3 iodothyronine deiodinase: cloning, in vitro expression and functional analysis of the placental selenoenzyme. J Clin Invest 95:2421-2430.